Translated title of the contribution | Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease. |
---|---|
Original language | Undefined/Unknown |
Pages (from-to) | 1708-1716 |
Number of pages | 9 |
Journal | Inflammatory bowel diseases |
Volume | 16 |
Issue number | 10 |
Publication status | Published - 2010 |
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.
C.J. van der Woude, P. Stokkers, A.A. van Bodegraven, G. van Assche, Z. Hebzda, L. Paradowski, G. D'Haens, S. Ghosh, B. Feagan, P. Rutgeerts, G. Dijkstra, D.J. de Jong, B. Oldenburg, M. Farhan, T. Richard, Y. Dean, D.W. Hommes
Research output: Contribution to journal › Article › Academic › peer-review